checkAd

     105  0 Kommentare AstroNova Reports Fiscal 2024 Fourth-Quarter and Full-Year Financial Results

    AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, today reported financial results for the fiscal 2024 fourth quarter and full year ended January 31, 2024.

    CEO Commentary

    “We capped a year of solid growth in fiscal 2024 with a strong fourth quarter that highlighted our strategic focus on enhancing margins and maintaining disciplined cost management, while continuing to invest for the future,” said Greg Woods, AstroNova’s President and Chief Executive Officer. “Our fourth-quarter operating income of $3.9 million joined our third quarter as the two best quarters in our history, and reflected contributions from both our Product Identification (PI) and Test & Measurement (T&M) segments.

    “T&M generated a 28% segment operating profit for the quarter on 10% top-line growth, driven primarily by the continued momentum of our Aerospace product line. The rebound in airline passenger traffic toward pre-pandemic levels, the increasing number of daily flights and favorable commercial aircraft order and delivery trends provide a favorable growth runway for our business. The data acquisition product line within our T&M segment also performed well in the quarter.

    “Our PI segment delivered strong year-over-year margin improvement in the quarter. Segment operating profit increased a healthy 560 basis points from the fourth quarter of fiscal 2023, in part reflecting the success of the strategic realignment announced last summer,” Woods said. “Additionally, at the end of the quarter we completed the previously discussed retrofit program of certain PI printers affected by faulty ink provided by one of our larger suppliers. On the innovation front, our PI development teams recently launched new digital printers and accessories under both our flagship QuickLabel and TrojanLabel brands.

    “Looking ahead, we see several growth opportunities for our business,” Woods said. “We are focused on applying the tools of the AstroNova Operating System to drive sustained product innovation, operating efficiencies and margin improvement. Our fiscal 2025 financial targets and outlook, which we are introducing today, reflect both confidence in the dynamics that are driving demand across our end markets and our commitment to continuing the margin improvement programs that we kicked off in FY24.”

    FY 2025 Financial Targets and Outlook

    For fiscal 2025, AstroNova expects to achieve full-year organic revenue percentage growth in the mid-single digits. Additionally, as AstroNova continues to drive operational improvements throughout the business, the Company expects its full-year adjusted EBITDA margin to be 13% to 14% this year and further improve by 100 basis points per year over the following two fiscal years.

    Q4 FY 2024 Financial Results

     

    GAAP

     

    Non-GAAP

    ($ in thousands, except per share data)

    Q4 FY 2024

    Q4 FY 2023

    YoY

    Q4 FY 2024

    Q4 FY 2023

    YoY

     

     

     

     

     

     

     

     

    Revenue

    $39,594

    $39,853

    (1%)

     

     

     

     

    Gross Profit

    $14,746

    $13,562

    9%

     

    $14,504

    $13,562

    9%

    Gross Margin

    37.2%

    34.0%

    320 pts.

     

    36.6%

    34.0%

    260 pts.

    Operating Expenses

    $10,831

    $11,465

    (6%)

     

    $10,874

    $11,465

    (5%)

    Operating Income

    $3,915

    $2,097

    87%

     

    $3,630

    $2,097

    73%

    Operating Margin

    9.9%

    5.3%

    460 pts.

     

    9.2%

    5.3%

    390 pts.

    Net Income

    $2,711

    $1,363

    99%

     

    $2,491

    $1,363

    83%

    Net Income per Common Share

    $0.36

    $0.18

    100%

     

    $0.33

    $0.18

    83%

    Adjusted EBITDA

     

     

     

     

    $5,521

    $3,930

    40%

    Adjusted EBITDA Less Restructuring & Retrofit-Related Items

     

     

     

     

    $5,236

    $3,930

    33%

    Full reconciliations between GAAP and Non-GAAP items are provided below.

    FY 2024 Financial Results

     

    GAAP

     

    Non-GAAP

    ($ in thousands, except per share data)

    FY 2024

    FY 2023

    YoY

    FY 2024

    FY 2023

    YoY

     

     

     

     

     

     

     

     

    Revenue

    $148,086

    $142,527

    4%

     

     

     

     

    Gross Profit

    $51,621

    $48,156

    7%

     

    $54,327

    $48,156

    13%

    Gross Margin

    34.9%

    33.8%

    330 pts.

     

    36.7%

    33.8%

    290 pts.

    Operating Expenses

    $42,825

    $42,713

    0%

     

    $42,313

    $41,996

    1%

    Operating Income

    $8,796

    $5,443

    62%

     

    $12,014

    $6,160

    95%

    Operating Margin

    5.9%

    3.8%

    210 pts.

     

    8.1%

    4.3%

    380 pts.

    Net Income

    $4,694

    $2,661

    76%

     

    $7,180

    $3,201

    124%

    Net Income per Common Share

    $0.63

    $0.36

    75%

     

    $0.97

    $0.43

    126%

    Adjusted EBITDA

     

     

     

     

    $14,383

    $10,294

    40%

    Adjusted EBITDA Less Restructuring & Retrofit-Related Items

     

     

     

     

    $17,601

    $11,010

    60%

    Full reconciliations between GAAP and Non-GAAP items are provided below.

    Revenue by Type

    ($ in thousands)

     

    Q4 FY 2024

    Q4 FY 2023

    YoY

     

    FY 2024

    FY 2023

    YoY

    Hardware

     

    $13,640

    $12,561

    9%

     

    $49,440

    $42,445

    17%

    Supplies

     

    $20,507

    $22,016

    (7%)

     

    $79,252

    $82,072

    (3%)

    Service/Other

     

    $5,446

    $5,277

    3%

     

    $19,394

    $18,010

    8%

    Adjusted EBITDA was $5.5 million in the fourth quarter of fiscal 2024 versus $3.9 million in the year earlier period. Further adjusted to exclude restructuring and retrofit-related items, Adjusted EBITDA was $5.2 million in the 2024 period. For the full year, Adjusted EBITDA was $14.4 million compared with $10.3 million in the comparable period of fiscal 2023. Further adjusted to exclude restructuring and retrofit-related items, Adjusted EBITDA was $17.6 million in fiscal 2024 compared with $11.0 million in fiscal 2023.

    Bookings in the fourth quarter of fiscal 2024 were $39.8 million, compared with $36.3 million in the fourth quarter of fiscal 2023, reflecting an increase in orders for both segments. Bookings were $143.7 million in fiscal 2024, compared with $138.6 million in fiscal 2023.

    Backlog as of January 31, 2024 was $31.4 million versus $35.8 million at the end of fiscal 2023.

    Segment Results

    Product Identification

    Product Identification (PI) segment revenue was $26.6 million in the fourth quarter of fiscal 2024, compared with $28.1 million in the fiscal 2023 fourth quarter. Segment operating profit was $3.2 million, or 12.2% of segment revenue, compared with segment operating profit of $1.9 million, or 6.6% of segment revenue, in the fourth quarter of fiscal 2023, reflecting more favorable mix in the 2024 period.

    For fiscal full-year 2024, Product Identification revenue increased to $104.0 million from $103.1 million for fiscal full-year 2023. Segment operating profit was $10.1 million, or 9.7% of segment revenue, in fiscal 2024 compared with segment operating profit of $7.9 million, or 7.7% of segment revenue, in fiscal 2023.

    Test & Measurement

    Test & Measurement (T&M) segment revenue increased to $13.0 million in the fourth quarter of fiscal 2024 from $11.7 million in the fourth quarter of fiscal 2023, primarily as a result of favorable pricing actions and the continued recovery of the commercial aviation market. Segment operating profit was $3.7 million, or 28.2% of segment revenue, compared with segment operating profit of $3.2 million, or 27.3% of segment revenue, in the fourth quarter of fiscal 2023, reflecting higher revenues, increased manufacturing efficiencies and favorable pricing actions.

    For fiscal full-year 2024, Test & Measurement revenue was $44.0 million, compared with $39.4 million in fiscal full-year 2023. Segment operating profit was $10.2 million, or 23.2% of segment revenue, in fiscal 2024, compared with $9.0 million, or 22.8% of segment revenue, in fiscal 2023.

    Earnings Conference Call Information

    AstroNova will discuss its fourth-quarter and full-year fiscal 2024 financial results and business outlook in an investor conference call at 9:00 a.m. ET today. To access the conference call, please dial (833) 470-1428 (U.S. and Canada) or (404) 975-4839 (International) approximately 10 minutes prior to the start time and enter access code 966245. A real-time and an archived audio webcast of the call will be available through the “Investors” section of the AstroNova website, https://investors.astronovainc.com.

    Use of Non-GAAP Financial Measures

    In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures Adjusted EBITDA, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, and non-GAAP net income per common share.

    We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation and acquisition-related costs. We define non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, and non-GAAP net income per common share, as the respective GAAP measure, excluding the impact of acquisition-related costs and restructuring and retrofit-related items.

    AstroNova believes that the inclusion of these non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a non-GAAP basis. AstroNova’s management uses these non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation tables included in this news release for a reconciliation of GAAP measures to the most directly comparable non-GAAP measures for the three and 12 months ended January 31, 2024 and January 31, 2023.

    AstroNova has not reconciled the forward-looking Adjusted EBITDA growth percentage included in its 2025 financial targets and outlook to the most directly comparable forward-looking GAAP measure because this cannot be done without unreasonable effort due to the lack of predictability regarding cost of sales, operating expenses, depreciation and amortization, and stock-based compensation. The impact of any of these items, individually or in the aggregate, may be significant.

    About AstroNova

    AstroNova (Nasdaq: ALOT), a global leader in data visualization technologies since 1969, designs, manufactures, distributes, and services a broad range of products that acquire, store, analyze, and present data in multiple formats.

    The Product Identification segment provides a wide array of digital, end-to-end product marking and identification solutions, including hardware, software, and supplies for OEMs, commercial printers, and brand owners. The Test and Measurement segment provides products designed for airborne printing solutions, avionics, and data acquisition. Our aerospace products include flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. Our data acquisition systems are used in research and development, flight testing, missile and rocket telemetry production monitoring, power, and maintenance applications.

    AstroNova is a member of the Russell Microcap Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is available by visiting https://astronovainc.com/.

    Forward-Looking Statements

    Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that we may not be able to realize the expected synergies from our acquisition of Astro Machine, (ii) the risk that apparent improvements in the Aerospace and Defense sectors may not continue and (iii) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2023 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

    ASTRONOVA, INC.
    Condensed Consolidated Statements of Income
    In Thousands Except for Per Share Data
    (Unaudited)
     
    Three Months Ended Twelve Months
    January 31,
    2024
    January 31,
    2023
    January 31,
    2024
    January 31,
    2023
    Net Revenue

    $

    39,594

     

    $

    39,853

     

    $

    148,086

     

    $

    142,527

     

    Cost of Revenue

     

    24,848

     

     

    26,291

     

     

    96,465

     

     

    94,371

     

    Gross Profit

     

    14,746

     

     

    13,562

     

     

    51,621

     

     

    48,156

     

    Total Gross Profit Margin

     

    37.2

    %

     

    34.0

    %

     

    34.9

    %

     

    33.8

    %

    Operating Expenses:
    Selling & Marketing

     

    5,977

     

     

    6,686

     

     

    24,428

     

     

    24,456

     

    Research & Development

     

    1,878

     

     

    1,801

     

     

    6,906

     

     

    6,822

     

    General & Administrative

     

    2,976

     

     

    2,978

     

     

    11,491

     

     

    11,435

     

    Total Operating Expenses

     

    10,831

     

     

    11,465

     

     

    42,825

     

     

    42,713

     

    Operating Income

     

    3,915

     

     

    2,097

     

     

    8,796

     

     

    5,443

     

    Total Operating Margin

     

    9.9

    %

     

    5.3

    %

     

    5.9

    %

     

    3.8

    %

    Other Expense, net

     

    563

     

     

    367

     

     

    2,723

     

     

    2,033

     

    Income Before Taxes

     

    3,352

     

     

    1,730

     

     

    6,073

     

     

    3,410

     

    Income Tax Provision

     

    641

     

     

    367

     

     

    1,379

     

     

    749

     

    Net Income

    $

    2,711

     

    $

    1,363

     

    $

    4,694

     

    $

    2,661

     

    Net Income per Common Share - Basic

    $

    0.36

     

    $

    0.19

     

    $

    0.63

     

    $

    0.36

     

    Net Income per Common Share - Diluted

    $

    0.36

     

    $

    0.18

     

    $

    0.63

     

    $

    0.36

     

     
    Weighted Average Number of Common Shares - Basic

     

    7,438

     

     

    7,330

     

     

    7,415

     

     

    7,307

     

    Weighted Average Number of Common Shares - Diluted

     

    7,550

     

     

    7,406

     

     

    7,496

     

     

    7,374

     

    ASTRONOVA, INC.
    Consolidated Balance Sheets
    In Thousands
    (Unaudited)
     
    January 31,
    2024
    January 31,
    2023
    ASSETS
    CURRENT ASSETS
    Cash and Cash Equivalents

    $

    4,527

     

    $

    3,946

     

    Accounts Receivable, net

     

    23,056

     

     

    21,598

     

    Inventories, net

     

    46,371

     

     

    51,324

     

    Prepaid Expenses and Other Current Assets

     

    2,606

     

     

    2,894

     

    Total Current Assets

     

    76,560

     

     

    79,762

     

    PROPERTY, PLANT AND EQUIPMENT

     

    57,046

     

     

    55,394

     

    Less Accumulated Depreciation

     

    (42,861

    )

     

    (41,106

    )

    Property, Plant and Equipment, net

     

    14,185

     

     

    14,288

     

    OTHER ASSETS
    Intangible Assets, net

     

    18,836

     

     

    21,232

     

    Goodwill

     

    14,633

     

     

    14,658

     

    Deferred Tax Assets

     

    6,882

     

     

    6,907

     

    Right of Use Asset

     

    603

     

     

    794

     

    Other Assets

     

    1,438

     

     

    1,566

     

    TOTAL ASSETS

    $

    133,137

     

    $

    139,207

     

    LIABILITIES AND SHAREHOLDERS’ EQUITY
    CURRENT LIABILITIES
    Accounts Payable

    $

    8,068

     

    $

    8,479

     

    Accrued Compensation

     

    2,923

     

     

    2,750

     

    Other Liabilities and Accrued Expenses

     

    2,706

     

     

    3,308

     

    Revolving Line of Credit

     

    8,900

     

     

    15,900

     

    Current Portion of Long-Term Debt

     

    2,842

     

     

    2,100

     

    Current Portion of Royalty Obligation

     

    1,700

     

     

    1,725

     

    Current Liability – Excess Royalty Payment Due

     

    935

     

     

    562

     

    Income Taxes Payable

     

    235

     

     

    786

     

    Deferred Revenue

     

    1,338

     

     

    1,888

     

    Total Current Liabilities

     

    29,647

     

     

    37,498

     

    NON-CURRENT LIABILITIES
    Long-Term Debt, net of current portion

     

    10,050

     

     

    12,040

     

    Royalty Obligation, net of current portion

     

    2,093

     

     

    3,415

     

    Lease Liability, net of current portion

     

    415

     

     

    555

     

    Income Tax Payables

     

    551

     

     

    491

     

    Deferred Revenue

     

    -

     

     

    674

     

    Deferred Tax Liabilities

     

    99

     

     

    167

     

    TOTAL LIABILITIES

     

    42,855

     

     

    54,840

     

    SHAREHOLDERS’ EQUITY
    Common Stock

     

    541

     

     

    534

     

    Additional Paid-in Capital

     

    62,684

     

     

    61,131

     

    Retained Earnings

     

    63,868

     

     

    59,175

     

    Treasury Stock

     

    (34,592

    )

     

    (34,235

    )

    Accumulated Other Comprehensive Loss, net of tax

     

    (2,219

    )

     

    (2,238

    )

    TOTAL SHAREHOLDERS’ EQUITY

     

    90,282

     

     

    84,367

     

    TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

    $

    133,137

     

    $

    139,207

     

    ASTRONOVA, INC.
    Revenue and Segment Operating Profit
    In Thousands
    (Unaudited)
     
    Revenue Segment Operating Profit Revenue Segment Operating Profit
    Three Months Ended Three Months Ended Twelve Months Ended Twelve Months Ended
    January 31,
    2024
    January 31,
    2023
    January 31,
    2024
    January 31,
    2023
    January 31,
    2024
    January 31,
    2023
    January 31,
    2024
    January 31,
    2023
    Product Identification

    $

    26,626

    $

    28,105

    $

    3,239

     

    $

    1,869

     

    $

    104,041

    $

    103,089

    $

    10,087

     

    $

    7,889

     

    Test & Measurement

     

    12,968

     

    11,748

     

    3,652

     

     

    3,206

     

     

    44,045

     

    39,438

     

    10,200

     

     

    8,989

     

    Total

    $

    39,594

    $

    39,853

     

    6,891

     

     

    5,075

     

    $

    148,086

    $

    142,527

     

    20,287

     

     

    16,878

     

    Corporate Expenses

     

    2,976

     

     

    2,978

     

     

    11,491

     

     

    11,435

     

    Operating Income

     

    3,915

     

     

    2,097

     

     

    8,796

     

     

    5,443

     

    Other Income (Expense), net

     

    (563

    )

     

    (367

    )

     

    (2,723

    )

     

    (2,033

    )

    Income Before Income Taxes

     

    3,352

     

     

    1,730

     

     

    6,073

     

     

    3,410

     

    Income Tax Provision

     

    641

     

     

    367

     

     

    1,379

     

     

    749

     

    Net Income

    $

    2,711

     

    $

    1,363

     

    $

    4,694

     

    $

    2,661

     

    ASTRONOVA, INC.
    Reconciliation of GAAP to Non-GAAP Results
    In Thousands Except for Per Share Data
    (Unaudited)
         
    Three Months Ended   Twelve Months Ended  
    January 31,
    2024
    January 31,
    2023
      January 31,
    2024
    January 31,
    2023
     
         
    GAAP Revenues

    $

    39,594

     

    $

    39,853

     

    $

    148,086

     

    $

    142,527

     

    Non-GAAP Revenues

    $

    39,594

     

    $

    39,853

     

    $

    148,086

     

    $

    142,527

     

         
    GAAP Cost of Revenues

    $

    24,848

     

    $

    26,291

     

    $

    96,465

     

    $

    94,371

     

    Restructuring Charges, net

     

    (32

    )

     

    -

     

     

    2,064

     

     

    -

     

    Product Retrofit Costs, net

     

    (410

    )

     

    -

     

     

    642

     

     

    -

     

    Non-GAAP Cost of Revenues

    $

    25,290

     

    $

    26,291

     

    $

    93,759

     

    $

    94,371

     

         
    GAAP Gross Profit

    $

    14,746

     

    $

    13,562

     

    $

    51,621

     

    $

    48,156

     

    Restructuring Charges, net

     

    (32

    )

     

    -

     

     

    2,064

     

     

    -

     

    Product Retrofit Costs, net

     

    (210

    )

    -

     

    642

     

     -

    Non-GAAP Gross Profit

    $

    14,504

     

    $

    13,562

     

    $

    54,327

     

    $

    48,156

     

         
    GAAP Operating Expenses

    $

    10,831

     

    $

    11,465

     

    $

    42,825

     

    $

    42,713

     

    Transaction Costs

     

    -

     

     

    -

     

     

    -

     

     

    (717

    )

    Restructuring Charges, net

     

    43

     

     

    -

     

     

    (512

    )

     

    -

     

    Non-GAAP Operating Expenses

    $

    10,874

     

    $

    11,465

     

    $

    42,313

     

    $

    41,996

     

         
    GAAP Operating Income

    $

    3,915

     

    $

    2,097

     

    $

    8,796

     

    $

    5,443

     

    Transaction Costs

     

    -

     

     

    -

     

     

    -

     

     

    717

     

    Restructuring Charges, net

     

    (75

    )

     

    -

     

     

    2,576

     

     

    -

     

    Product Retrofit Costs, net

     

    (210

    )

     

    -

     

     

    642

     

     

    -

     

    Non-GAAP Operating Income

    $

    3,630

     

    $

    2,097

     

    $

    12,014

     

    $

    6,160

     

         
    GAAP Other Income/(Expense)

    $

    (563

    )

    $

    (367

    )

    $

    (2,723

    )

    $

    (2,033

    )

    Non-GAAP Other Income/(Expense)

    $

    (563

    )

    $

    (367

    )

    $

    (2,723

    )

    $

    (2,033

    )

         
    GAAP Income Tax Expense

    $

    641

     

    $

    367

     

    $

    1,379

     

    $

    749

     

    Tax Adjustments of Non-GAAP Adjustments

     

    (65

    )

     

    -

     

     

    732

     

     

    177

     

    Non-GAAP Income Tax Expense

    $

    576

     

    $

    367

     

    $

    2,111

     

    $

    926

     

         
    GAAP Net Income

    $

    2,711

     

    $

    1,363

     

    $

    4,694

     

    $

    2,661

     

    Transaction Costs

     

    -

     

     

    -

     

     

    -

     

     

    540

     

    Restructuring Charges, net

     

    (58

    )

     

    -

     

     

    1,990

     

     

    -

     

    Product Retrofit Costs, net

     

    (162

    )

     

    -

     

     

    496

     

     

    -

     

    Non-GAAP Net Income

    $

    2,491

     

    $

    1,363

     

    $

    7,180

     

    $

    3,201

     

         
    GAAP Diluted Earnings Per Share

    $

    0.36

     

    $

    0.18

     

    $

    0.63

     

    $

    0.36

     

    Transaction Costs

     

    -

     

     

    -

     

     

    -

     

     

    0.07

     

    Restructuring Charges, net

     

    (0.01

    )

     

    -

     

     

    0.27

     

     

    -

     

    Product Retrofit Costs, net

     

    (0.02

    )

     

    -

     

     

    0.07

     

     

    -

     

    Non-GAAP Diluted Earnings Per Share

    $

    0.33

     

    $

    0.18

     

    $

    0.97

     

    $

    0.43

     

    ASTRONOVA, INC.
    Reconciliation of Net Income to Adjusted EBITDA
    Amounts In Thousands
    (Unaudited)
     
    Three Months Ended Twelve Months Ended
    January 31,
    2024
    January 31,
    2023
    January 31,
    2024
    January 31,
    2023
    GAAP Net Income

    $

    2,711

     

    $

    1,363

    $

    4,694

    $

    2,661

    Interest Expense

     

    779

     

     

    592

     

    2,697

     

    1,678

    Income Tax Expense

     

    641

     

     

    367

     

    1,379

     

    749

    Depreciation/Amortization

     

    1,108

     

     

    1,295

     

    4,266

     

    3,916

    Share-Based Compensation

     

    282

     

     

    313

     

    1,347

     

    1,290

    Adjusted EBITDA

    $

    5,521

     

    $

    3,930

    $

    14,383

    $

    10,294

    Transaction Costs

     

    -

     

     

    -

     

    -

     

    540

    Restructuring Charges, net

     

    (58

    )

     

    -

     

    1,990

     

    -

    Product Retrofit Costs, net

     

    (162

    )

     

    -

     

    496

     

    -

    Income Tax Expense - Transaction Costs

     

    -

     

     

    -

     

    -

     

    176

    Income Tax Expense - Restructuring Charges, net

     

    (17

    )

     

    -

     

    586

     

    -

    Income Tax Expense - Product Retrofit Costs, net

     

    (48

    )

     

    -

     

    146

     

    -

    Adjusted EBITDA Less Restructuring & Retrofit Items

    $

    5,236

     

    $

    3,930

    $

    17,601

    $

    11,010

    ASTRONOVA, INC.
    Reconciliation of Segment GAAP to Non-GAAP Operating Income
    Amounts In Thousands
    (Unaudited)
     
    Three Months Ended Twelve Months Ended
    January 31, 2024 January 31, 2023 January 31, 2024 January 31, 2023
    Product
    Identification
    Test &
    Measurement
    Total Product
    Identification
    Test &
    Measurement
    Total Product
    Identification
    Test &
    Measurement
    Total Product
    Identification
    Test &
    Measurement
    Total
     
    GAAP - Segment Operating Profit

    $

    3,239

     

    $

    3,652

    $

    6,891

     

    $

    1,869

    $

    3,206

    $

    5,075

    $

    10,087

    $

    10,200

    $

    20,287

    $

    7,889

    $

    8,989

    $

    16,878

     
    Restructuring Charges, net

     

    (75

    )

     

    -

     

    (75

    )

     

    -

     

    -

     

    -

     

    2,494

    -

     

    2,494

     

    -

     

    -

     

    -

     
    Product Retrofit Costs, net

     

    (210

    )

     

    -

     

    (210

    )

     

    -

     

    -

     

    -

     

    642

    -

     

    642

     

    -

     

    -

     

    -

     
    Non-GAAP - Segment Operating Profit

    $

    2,954

     

    $

    3,652

    $

    6,606

     

    $

    1,869

    $

    3,206

    $

    5,075

    $

    13,223

    $

    10,200

    $

    23,423

    $

    7,889

    $

    8,989

    $

    16,878

     


    The AstroNova Stock at the time of publication of the news with a raise of +0,91 % to 16,55USD on Lang & Schwarz stock exchange (22. März 2024, 12:34 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    AstroNova Reports Fiscal 2024 Fourth-Quarter and Full-Year Financial Results AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, today reported financial results for the fiscal 2024 fourth quarter and full year ended January 31, 2024. CEO Commentary “We capped a year of solid growth in fiscal …